Company: PFSA
Filing Date: 2025-08-21
Form Type: S-1/A
Source: 0001213900-25-079401
Chunk: 345

Company: Profusa, Inc.
Filing Date: 2025-08-21
Form: S-1/A
Chunk 345
---
. Underwriters Agreement The underwriters had a 30 -dayoption from the date of IPO to purchase up to an additional 2,475,000units to cover over -allotments, if any. On December 22, 2021, the over -allotmentwas fully exercised. The underwriters received a cash underwriting discount of approximately 1.82% of the gross proceeds of the IPO, or $ 3,450,000. Business Combination Marketing Agreement Under a Business Combination marketing agreement, the Company engaged I -Bankersand Dawson James as advisors in connection with the Business Combination to assist the Company in holding meetings with the stockholders to discuss the potential Business Combination and the target business’s attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with the potential Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company was obligated to pay I -Bankersand Dawson James a cash fee for such marketing services upon the consummation of the initial Business Combination in an amount of 3.68% of the gross proceeds of the IPO, or $ 6,986,250. The agreement was amended on November 7, 2022 to allow for the 3.68% business combination fee to be paid as (a) 27.5% cash and (b) 72.5% to be rolled into equity at closing. Subsequently, on January19, 2025, the agreement was modified by the parties such that the Company will be required to pay $ 2,000,000, payable in cash, if a business combination is consummated. Representative’s Shares On December 22, 2021, the Company issued 450,000shares (Representative Shares) of common stock (which included 37,500Representative Shares issued pursuant to the full exercise of the over -allotmentoption) at the consummation of the IPO to I -Bankersand Dawson James (and/or their designees). I -Bankersand Dawson James (and/or their designees) have agreed not to transfer, assign or sell any such shares until the completion of the initial Business Combination. In addition, I -Bankersand Dawson James (and/or their designees) have agreed (i) to waive their F-73 NORTHVIEW ACQUISITION CORPORATION
NOTES TO CONSOLIDATED